Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$680.49 - $826.97 $4.75 Million - $5.77 Million
-6,979 Reduced 96.45%
257 $211,000
Q3 2022

Nov 01, 2022

SELL
$573.97 - $724.32 $8,609 - $10,864
-15 Reduced 0.21%
7,236 $4.99 Million
Q2 2022

Aug 25, 2022

SELL
$548.35 - $738.84 $58,673 - $79,055
-107 Reduced 1.45%
7,251 $4.29 Million
Q1 2022

May 13, 2022

SELL
$595.12 - $698.43 $7,736 - $9,079
-13 Reduced 0.18%
7,358 $5.14 Million
Q4 2021

Jan 18, 2022

SELL
$543.48 - $670.97 $7.25 Million - $8.95 Million
-13,337 Reduced 64.41%
7,371 $4.66 Million
Q3 2021

Nov 09, 2021

BUY
$574.03 - $680.96 $5.02 Million - $5.95 Million
8,741 Added 73.04%
20,708 $12.5 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $432,612 - $511,064
-915 Reduced 7.1%
11,967 $6.69 Million
Q1 2021

May 12, 2021

SELL
$446.73 - $548.2 $643,291 - $789,408
-1,440 Reduced 10.05%
12,882 $6.09 Million
Q4 2020

Feb 02, 2021

BUY
$478.3 - $607.98 $196,103 - $249,271
410 Added 2.95%
14,322 $6.92 Million
Q3 2020

Oct 26, 2020

SELL
$544.75 - $658.21 $777,358 - $939,265
-1,427 Reduced 9.3%
13,912 $7.79 Million
Q2 2020

Jul 22, 2020

BUY
$493.32 - $643.92 $3.26 Million - $4.26 Million
6,613 Added 75.79%
15,339 $9.57 Million
Q1 2020

Apr 09, 2020

SELL
$336.18 - $494.43 $547,637 - $805,426
-1,629 Reduced 15.73%
8,726 $4.26 Million
Q4 2019

Jan 28, 2020

BUY
$274.13 - $376.51 $2.84 Million - $3.9 Million
10,355 New
10,355 $3.88 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.